Improved breast cancer survival among hormone replacement therapy users is durable after 5 years of additional follow-up
To access this article, please choose from the options below
Dr. Rodney Pommier and Dr. SuEllen Pommier are consultants for Wyeth Pharmaceuticals.
PII: S0002-9610(08)00488-1
doi:10.1016/j.amjsurg.2008.06.023
© 2008 Elsevier Inc. All rights reserved.
